Burden of HIV and hepatitis C co‐infection: the changing epidemiology of hepatitis C in HIV‐infected patients in France
- 24 July 2014
- journal article
- review article
- Published by Wiley in Liver International
- Vol. 35 (1) , 65-70
Abstract
Background & Aims: To better evaluate the HIV–HCV co‐infection burden in the context of new effective HCV treatment.Methods: We reviewed all the epidemiological data available on HCV‐related disease in HIV‐infected patients in France. Sources of data have been selected using the following criteria: (i) prospective cohorts or cross‐sectional surveys; (ii) conducted at a national level; (iii) in the HIV‐infected population; (iv) able to identify HCV co‐infection and chronic active hepatitis C (HCV RNA positive); and (v) conducted during the period 2003–2012.Results: The overall prevalence of HIV–HCV co‐infection has decreased from 22–24% to 16–18%. This prevalence decreased from 93% to 87% among injecting drug users while it increased from 4% to 6% among men who have sex with men. The characteristics of patients have changed: decrease in the proportion of patients with chronic active hepatitis C (HCV RNA positive) from 77% to 63% and in the genotypes 2 and 3 HCV infection; increase in the proportion of HCV genotype 1 (from 45–50% to 58%) and genotype 4 (from 15% to 22%). The proportion of patients treated with highly active antiretroviral therapy increased from 76% to 95%, with higher rates of undetectable HIV viral load (47% in 2004 vs. 85% in 2012).Conclusion: The decreasing prevalence and the change in patients profile in HIV–HCV co‐infection underline the importance of continuing efforts to educate physicians and patients. This should increase the benefit of viral risk reduction policies and increase the access of co‐infected patients to HCV treatment.Keywords
This publication has 32 references indexed in Scilit:
- Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyHIV Medicine, 2012
- Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in SpainClinical Infectious Diseases, 2012
- 26 LIVER RELATED DEATHS IN HIV-INFECTED PATIENTS BETWEEN 2000 AND 2010. RESULTS OF THE FRENCH NATIONAL SURVEY “ANRS EN20 MORTALITE 2010”Journal of Hepatology, 2012
- The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010BMC Infectious Diseases, 2010
- Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: Modifications in three consecutive large surveys between 2004 and 2009Journal of Hepatology, 2010
- A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the designBMC Infectious Diseases, 2009
- Liver‐related mortality in human‐immunodeficiency‐virus‐infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)*Journal of Viral Hepatitis, 2006
- Hepatocellular carcinoma in HIV-infected patientsAIDS, 2004
- Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patientsAIDS, 2004
- Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)AIDS, 2003